NCT07689591|RecruitingDMC
Noninvasive Artificial Venous Stasis for Reperfusion in STEMI
RE-START
Loading search results
RE-START
Sponsor study identifier
observational
500
1 country
2
Study Start
August 15, 2026
Actual (reported)Primary Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 30, 2026
Actual (reported)July 8, 2026
Actual (reported)August 15, 2026
Actual (reported)December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Presence of Spontaneous Coronary Reperfusion Before Primary PCI
Spontaneous coronary reperfusion will be defined as the presence of TIMI flow grade 2 or 3 in the infarct-related artery on the first diagnostic coronary angiography performed before guidewire crossing and before primary percutaneous coronary intervention
Periprocedural
ST-Segment Resolution After Primary PCI
90 minutes after primary PCI
Left Ventricular Ejection Fraction
Within 48 hours after primary PCI
Peak-to-Baseline D-Dimer Ratio Through Day 3
From baseline to Day 3 or hospital discharge, whichever occurs first
NT-proBNP Level at Hospital Discharge
At hospital discharge
Contrast-Associated Acute Kidney Injury
From baseline to 48-72 hours after primary PCI
The study population will include adult patients admitted to Firat University Hospital with acute ST-segment elevation myocardial infarction who are eligible for and planned to undergo primary percutaneous coronary intervention. Eligible patients will be randomized before coronary angiography to either the RE-START procedure group or the sham-control group, without delaying standard STEMI management or primary PCI.
Firat University
Elâzığ, Elaziğ, 23000, Turkey (Türkiye)
Firat University
Elâzığ, Merkez, 23000, Turkey (Türkiye)
Araştırma katılımcılarından alınan materyal örneklerinin bir biyolojik örneği saklanmayacaktır.
MEHMET BALIN
Firat University
First Submitted
June 30, 2026
First Posted
July 8, 2026
Study Start
August 15, 2026
Actual (reported)Primary Completion
December 31, 2026
EstimatedReperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
August 18, 2026
Record last verified: 2026-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: